Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
Recruiting now · Not applicable
Conditions studied: Hematologic Malignancy, Neutropenia, Bone Pain
In brief
This is a comparative interventional study to determine the best way to prevent G-CSF induced bone pain in patients with hematological malignancies (blood cancers). G-CSF (Granulocyte Colony-Stimulating Factor) is a drug commonly used in these patients to boost white blood cell production, but it frequently causes severe bone pain. The study is comparing two oral medications for their effectiveness as a preventive treatment: * Diosmin-Hesperidin (a flavonoid supplement). * Loratadine (a common anti-allergy medication). The core question the study is trying to answer is: * Is diosmin-hesperidin effective in preventing G-CSF-induced bone pain compared to loratadine? * Does the combination of diosmin-hesperidin and loratadine offer better pain prevention than either drug alone?
Key facts
- Study ID
- NCT07300735
- Run by
- Alexandria University
- People needed
- 88
- Starts
- 2025-03-01
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-06-24
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults 18 to 65 years old
- Receiving a G-CSF for one of the following indications:
- Treatment of neutropenia along with treatment for leukemia or lymphoma Neutropenia prevention following autologous hematopoietic cell transplant
- Patients with or without bone pain associated with G-CSF administration.
- Willingness to provide informed consent to participate in the study.
You may not qualify if…
- Patients with solid tumors.
- Pregnant or breastfeeding women.
- Patients with known allergies or hypersensitivity to Loratadine, Diosmin- Hespiridin or Filgrastim.
- Patients with pre-existing bone disorders or receiving bone modifying agents
- Chronic use of antihistamines, Diosmin-Hespiridin, NSAIDs, corticosteroids, or immunosuppressants.
- Receiving medications with drug interaction grade X with Loratadine, Diosmin-Hespiridin or Filgrastim
- Patients who are unable to understand or provide informed consent
Where it is running
- Alexandria University Hospitals — Alexandria, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.